1 |
Machida, K., K. Tsukiyama-Kohara, E. Seike, S. Tone, F. Shibasaki, M. Shimizu, H. Takahashi, Y. Hayashi, N. Funata, C. Taya, H. Yonekawa and M. Kohara. 2001. Inhibition of cytochrome c release in Fas-mediated signaling pathway in transgenic mice induced to express hepatitis C viral proteins. J. Biol. Chem. 276, 12140-12146
DOI
ScienceOn
|
2 |
Schuster, R., W. H. Gerlich and S. Schaefer. 2000. Induction of apoptosis by the transactivating domains of the hepatitis B virus X gene leads to suppression of oncogenic transformation of primary rat embryo fibroblasts. Oncogene 19, 1173-1180
DOI
ScienceOn
|
3 |
Gottlob, K., M. Fulco, M. Levrero and A. Graessmann. 1998. The hepatitis B virus HBx protein inhibits caspase 3 activity. J. Biol. Chem. 273, 33347-33353
DOI
ScienceOn
|
4 |
Benvegnu, L. and A. Alberti. 2001. Patterns of hepatocellular carcinoma development in hepatitis B virus and hepatitis C virus related cirrhosis. Antiviral Res. 52, 199-207
DOI
ScienceOn
|
5 |
Villa, E., A. Grottola, P. Buttafoco, A. Colantoni, A. Bagni, I. Ferretti, C. Cremonini, H. Bertani and F. Manenti. 2001. High doses of alpha-interferon are required in chronic hepatitis due to coinfection with hepatitis B virus and hepatitis C virus: long term results of a prospective randomized trial. Am. J. Gastroenterol. 96, 2973-2977
|
6 |
Koike, K., T. Tsutsumi, H. Fujie, Y. Shintani and M. Kyoji. 2002. Molecular mechanism of viral hepatocarcinogenesis. Oncology 62 Suppl. 1, 29-37
DOI
ScienceOn
|
7 |
Ahn, J. Y., E. Y. Jung, H. J. Kwun, C. W. Lee, Y. C. Sung and K. L. Jang. 2002. Dual effects of hepatitis B virus X protein on the regulation of cell-cycle control depending on the status of cellular p53. J. Gen. Virol. 83, 2765-2772
DOI
|
8 |
Kwun H. J. and K. L. Jang. 2003. Dual effects of hepatitis C virus Core protein on the transcription of cyclin-dependent kinase inhibitor p21 gene. J. Viral. Hepat. 10, 249-255
DOI
ScienceOn
|
9 |
Qin, L. F. and I. O. Ng. 2002. Induction of apoptosis by cisplatin and its effect on cell cycle-related proteins and cell cycle changes in hepatoma cells. Cancer Lett. 175, 27-38
DOI
ScienceOn
|
10 |
Staib, F., S. P. Hussain, L. J. Hofseth, X. W. Wang and C. C. Harris. 2003. TP53 and liver carcinogenesis. Hum. Mutat. 21, 201-216
DOI
ScienceOn
|
11 |
Ahn, J. Y., E. Y. Chung, H. J. Kwun and K. L. Jang. 2001. Transcriptional repression of promoter by hepatitis B virus X protein via a p53-independent pathway. Gene 275, 163-168
DOI
ScienceOn
|
12 |
Han, H. J., E. Y. Jung, W. J. Lee and K. L. Jang. 2002. Cooperative repression of cyclin-dependent kinase inhibitor p21 gene expression by hepatitis B virus X protein and hepatitis C virus core protein. FEBS Lett. 518, 169-172
DOI
ScienceOn
|
13 |
Gorman, C. M., G. T. Merlino, M. C. Willingham, I. Pastan and B. H. Howard. 1982. The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc. Natl. Acad. Sci. USA 79, 6777-6781
DOI
|
14 |
Sionov, R. V. and Y. Haupt. 1999. The cellular response to p53: the decision between life and death. Oncogene 18, 6145-6157
DOI
ScienceOn
|
15 |
Oren, M. 2003. Decision making by p53: life, death and cancer. Cell Death Differ. 10, 431-442
DOI
ScienceOn
|
16 |
Vermeulen, K., Z. N. Berneman and D. R. Van Bockstaele. 2003. Cell cycle and apoptosis. Cell Prolif. 36, 165-175
DOI
ScienceOn
|
17 |
Cory, S. and J. M. Adams. 2002. The Bcl2 family: regulators of the cellular life-or-death switch. Nat. Rev. Cancer 2, 647-656
DOI
ScienceOn
|
18 |
Henkler, F. and R. Koshy. 1996. Hepatitis B virus transcriptional activators: mechanisms and possible role in oncogenesis. Viral Hepat. Rev. 2, 143-159
|